Thorne Research Overview

  • Founded
  • 1984
Founded
  • Status
  • Public
  • Employees
  • 456
Employees
  • Stock Symbol
  • THRN
Stock Symbol
  • Investments
  • 6
  • Share Price
  • $7.72
  • (As of Wednesday Closing)

Thorne Research General Information

Description

Thorne HealthTech Inc is developing the innovative solutions for a personalized approach to health and wellbeing. It is a science-driven wellness company that is utilizing testing and data to create improved product efficacy and deliver personalized solutions to consumers, health professionals and corporations. Thorne HealthTech's unique, vertically integrated brands, Thorne and Onegevity, provide insights and personalized data, products, and services that help individuals take a proactive and actionable approach to improving and maintaining health over a lifetime.

Contact Information

Website
www.thorne.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Food Products
Stock Exchange
NAS
Primary Office
  • 152 West 57th Street
  • 10th Floor
  • New York, NY 10019
  • United States
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Thorne Research Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.72 $7.84 $7.38 - $8.90 $412M 52.5M 414K $0.16

Thorne Research Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2017 31-Dec-2017
Revenue 162,325 138,455 102,532 89,151
EBITDA 16,414 3,154 (11,554)
Net Income 6,898 (3,358) (16,724)
Total Assets 130,591 115,489 101,006
Total Debt 54,308 51,305 40,586
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Thorne Research Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Thorne Research‘s full profile, request access.

Request a free trial

Thorne Research Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Thorne HealthTech Inc is developing the innovative solutions for a personalized approach to health and wellbeing. It is
Pharmaceuticals
New York, NY
456 As of 2021
0000
0000 0000-00-00
00000000 0000

0000 000

boris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate v
0000 000000000
Fort Lauderdale, FL
000 As of 0000

0000000

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariat
000000000000000
Orlando, FL
000 As of 0000
00.000
0000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Thorne Research Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Life Extension (Florida) Corporation Fort Lauderdale, FL 000
0000000 Angel-Backed Orlando, FL 000 00.000 0000000000 00.000
0000000 000 000000 Private Debt Financed Suffield, CT 000 0000 00000.
0000 0000000000000 Formerly PE-Backed Sudbury, MA 000000000000
0000000000 Formerly PE-Backed Aliso Viejo, CA 000 0000 000000000000
To view Thorne Research’s complete competitors history, request access »

Thorne Research Patents

Thorne Research Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170014374-A1 Composition for treatment of dyslipidemia and inflammation Abandoned 13-Jul-2015 0000000000
US-5977184-A Antiallergens Expired - Lifetime 15-Sep-1995 0000000000 00

Thorne Research Executive Team (13)

Name Title Board Seat Contact Info
Scott Wheeler Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Tom McKenna Chief Operating Officer & Board Member
Scott Hurth Chief Technology Officer, Technology
Michelle Crow Chief Marketing Officer, Marketing
Bodi Zhang Chief Scientific Officer
You’re viewing 5 of 13 executive team members. Get the full list »

Thorne Research Board Members (9)

Name Representing Role Since
00000000 0000000 Self Board Member 000 0000
000 0000000 Thorne Research Chief Operating Officer & Board Member 000 0000
000000000 0000000 Thorne Research Board Member 000 0000
00000000 000 Thorne Research Board Member 000 0000
You’re viewing 4 of 9 board members. Get the full list »

Thorne Research Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Thorne Research Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Thorne Research‘s full profile, request access.

Request a free trial

Thorne Research Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 000000 25-May-2021 000000000000000000 Diagnostic Equipment 0000 00000000
000000000 25-Feb-2021 000000000000000000 Other Healthcare Technology Systems 0000 00000000
000 000000000000 21-Aug-2019 00000 0000000 Pharmaceuticals 0000 00000000
0000000000 000000 24-Jul-2019 00000 00000 00 000 Diagnostic Equipment 0000 00000000
Diversified Natural Products 23-Jun-2010 Buyout/LBO Agricultural Chemicals
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Thorne Research Subsidiaries (2)

Company Name Industry Location Founded
Onegevity Acquirer New York, NY 2018
0000000000 000000 Diagnostic Equipment Menlo Park, CA 0000
To view Thorne Research’s complete subsidiaries history, request access »